Effect of Empagliflozin with or without the Addition of Evolocumab on HDL Subspecies in Individuals with Type 2 Diabetes Mellitus: A Post Hoc Analysis of the EXCEED-BHS3 Trial
Article in International Journal of Molecular Sciences (April 2024)
The most recent citing publications are shown below. View all 81 publications that cite this research output on Dimensions.
The effects of sodium-glucose cotransporters type 2 inhibitors on glycemic and extraglycemic laboratory parameters
Article in International Journal of Diabetes in Developing Countries (January 2024)
Antioxidant and Anti-Inflammatory Functions of High-Density Lipoprotein in Type 1 and Type 2 Diabetes
Article in Antioxidants (December 2023)